SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

NENCI, Italo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.642
AS - Asia 3.010
EU - Europa 2.431
SA - Sud America 539
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 2
Totale 11.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.472
SG - Singapore 1.150
IT - Italia 919
CN - Cina 782
BR - Brasile 417
DE - Germania 370
VN - Vietnam 301
UA - Ucraina 297
HK - Hong Kong 221
GB - Regno Unito 200
TR - Turchia 193
FI - Finlandia 122
FR - Francia 118
SE - Svezia 104
CA - Canada 95
RU - Federazione Russa 76
IN - India 73
BD - Bangladesh 67
JP - Giappone 59
MX - Messico 57
NL - Olanda 53
BE - Belgio 41
PL - Polonia 41
AR - Argentina 36
ID - Indonesia 30
ZA - Sudafrica 30
ES - Italia 24
EC - Ecuador 23
IQ - Iraq 23
PK - Pakistan 21
VE - Venezuela 16
CL - Cile 14
AT - Austria 12
CZ - Repubblica Ceca 12
CO - Colombia 11
UZ - Uzbekistan 11
MA - Marocco 10
PH - Filippine 10
AE - Emirati Arabi Uniti 8
CH - Svizzera 7
KE - Kenya 7
MY - Malesia 7
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
AL - Albania 6
AZ - Azerbaigian 6
IR - Iran 6
PE - Perù 6
RO - Romania 6
AO - Angola 5
BO - Bolivia 5
LT - Lituania 5
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
OM - Oman 4
SV - El Salvador 4
CR - Costa Rica 3
HR - Croazia 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
KR - Corea 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MG - Madagascar 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PS - Palestinian Territory 1
Totale 11.695
Salva come PNG Salva come JPEG
Città #
Singapore 745
Ashburn 573
San Jose 456
Woodbridge 367
Chandler 321
Jacksonville 296
Santa Clara 277
Ann Arbor 274
Fairfield 263
Beijing 235
Hong Kong 218
Houston 216
New York 152
Council Bluffs 148
Wilmington 116
Izmir 112
Los Angeles 108
Seattle 107
Dallas 99
Ho Chi Minh City 94
Cambridge 89
Munich 84
Nanjing 84
Hanoi 81
Milan 64
Princeton 62
Bremen 60
Tokyo 58
Buffalo 56
Lauterbourg 49
Rome 48
Dearborn 47
Shanghai 47
São Paulo 46
Brussels 40
Brooklyn 39
Mexico City 37
Helsinki 36
Nanchang 34
Hefei 33
Toronto 32
Turku 31
Warsaw 31
Boardman 30
Ferrara 30
San Diego 30
Orem 29
Hebei 28
Tianjin 28
Montreal 25
Atlanta 24
Chennai 23
Denver 23
London 22
Shenyang 22
Johannesburg 21
Manchester 20
Phoenix 18
San Mateo 18
Stockholm 18
Chicago 17
San Francisco 17
Changsha 16
Frankfurt am Main 16
Jakarta 16
Amsterdam 15
Auburn Hills 15
Bologna 15
Falls Church 15
Rio de Janeiro 15
Poplar 14
Zhengzhou 14
Baghdad 13
Belo Horizonte 13
Boston 13
Haiphong 13
Jinan 13
Palermo 13
Ankara 12
Brasília 12
Da Nang 12
Falkenstein 12
Jiaxing 12
Querétaro 11
Tashkent 11
Guangzhou 10
Moscow 10
Mumbai 10
Philadelphia 10
Bari 9
Kunming 9
Naples 9
Napoli 9
Brno 8
Campinas 8
Florence 8
Guayaquil 8
Lahore 8
Nuremberg 8
Ottawa 8
Totale 7.251
Salva come PNG Salva come JPEG
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 668
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 572
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 268
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 264
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 239
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 233
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 220
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 215
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 210
Aneurysmal fibrous histiocytoma: Case report and review of the literature 209
Espressione dei MicroRNA nei carcinomi mammari 205
The 70 Gene Mammaprint signature: Ferrara's experience 198
Quantitative immunoprofiles of breast cancer performed by image analysis 197
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 196
Italy, Ferrara province 196
Registro Tumori della provincia di Ferrara 195
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 193
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 193
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 192
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 191
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 187
Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology 186
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 185
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 184
Diagnosi citologica molecolare integrata (reflex test) nella patologia neoplastica dell'urotelio. 181
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 180
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 178
High incidence of ependymomas induced by BK virus, a human papovavirus: brief communication. 177
Cancer Incidence in Ferrara Province (1998-2002) 175
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 173
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 173
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 171
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 171
Quantitative analysis of molecular markers MCM2, TOPO2A and KI-67 (Mib1) in squamous intraepithelial neoplasia in liquid-based cytology 169
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 169
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 168
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 167
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 161
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 161
Biological staging of incipient, in situ and invasive breast carcinomas 159
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 159
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 159
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 155
Markers of DNA-replication licensing systems in cervical dysplasia 152
Sentinel node and bone marrow micro metastases and nanometastases 147
Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes 134
Italy, Ferrara province 132
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 130
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 128
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 125
MicroRNA gene expression deregulation in human breast cancer 124
Linkage of biopsy, cancer, and population records aimed at the estimation of family risks in neoplasia: A pilot study 123
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 122
Italy, Ferrara 120
Italy, Ferrara Province 114
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 114
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 112
null 107
Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11 106
Immunohistochemistry expression of c-erbB-2 in human breast cancer by monoclonal antibody: Correlation with lymph node and ER status 105
null 98
null 93
null 86
null 85
Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods 79
null 75
null 64
Monoclonal Antibodies for Specific Immunoperoxidase Detection of Campylobacter pylori 40
null 32
Totale 11.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.718
Totale 52.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 0 74 32 60 65 19 18 48 23 46 60 222
2022/2023775 60 70 31 94 163 109 28 57 81 11 39 32
2023/2024409 44 24 32 16 24 101 17 40 8 9 19 75
2024/20251.696 59 37 113 48 211 190 56 92 268 178 237 207
2025/20264.457 437 151 389 594 690 314 522 198 430 484 181 67
2026/2027337 138 199 0 0 0 0 0 0 0 0 0 0
Totale 11.749